KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Shawn O’Neil of ViaLase discusses positive 24-month safety and efficacy data for the company’s noninvasive OCT-driven femtosecond laser for glaucoma treatment.
The laser showed no adverse events at 2 years, as well as a median IOP lowering of 32% in a case series of 17 eyes, he said.